Linli Tian Selected Research

18alpha,20beta- hydroxy- 11- oxo- norolean- 12- en- 3beta- yl- 2- O- beta- D- glucopyranurosyl- alpha- D- glucopyranosiduronate magnesium tetrahydrate

1/2020

Magnesium Isoglycyrrhizinate Induces an Inhibitory Effect on Progression and Epithelial-Mesenchymal Transition of Laryngeal Cancer via the NF-κB/Twist Signaling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Linli Tian Research Topics

Disease

20	Neoplasms (Cancer) 02/2024 - 04/2008
11	Squamous Cell Carcinoma of Head and Neck 01/2024 - 06/2014
9	Laryngeal Neoplasms (Laryngeal Cancer) 01/2023 - 12/2008
8	Carcinogenesis 12/2023 - 06/2014
4	Neoplasm Metastasis (Metastasis) 01/2024 - 01/2016
4	Squamous Cell Neoplasms (Squamous Cell Cancer) 01/2020 - 01/2016
2	Carcinoma (Carcinomatosis) 01/2023 - 09/2011
2	Nasopharyngeal Carcinoma 01/2022 - 01/2020
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2019 - 04/2008
1	Lymphatic Metastasis 02/2024
1	Tertiary Lymphoid Structures 01/2024
1	Hypersensitivity (Allergy) 01/2023
1	Allergic Rhinitis 01/2023
1	Foreign Bodies (Foreign Body) 01/2022
1	Inflammation (Inflammations) 01/2020
1	Rhinosinusitis 01/2019
1	Polyps 01/2016

Drug/Important Bio-Agent (IBA)

10	Long Noncoding RNAIBA 12/2023 - 01/2016
7	MicroRNAs (MicroRNA)IBA 10/2017 - 12/2010
3	Circular RNAIBA 01/2020 - 01/2016
3	Biomarkers (Surrogate Marker)IBA 02/2017 - 09/2014
2	Small Untranslated RNAIBA 06/2023 - 12/2010
2	6-methyladenineIBA 01/2022 - 02/2021
1	Annexin A3IBA 02/2024
1	Immune Checkpoint InhibitorsIBA 01/2024
1	Transcription Factors (Transcription Factor)IBA 10/2023
1	Transfer RNA (tRNA)IBA 06/2023
1	Tyrosine (L-Tyrosine)FDA Link 06/2023
1	Lactic Acid (Lactate)FDA LinkGeneric 06/2023
1	RNA (Ribonucleic Acid)IBA 06/2023
1	Interleukin-17 (Interleukin 17)IBA 01/2023
1	Thymic Stromal LymphopoietinIBA 01/2023
1	Histamine (Histamine Dihydrochloride)FDA Link 01/2023
1	Immunoglobulin E (IgE)IBA 01/2023
1	LigandsIBA 01/2023
1	MucinsIBA 01/2023
1	Interleukin-33IBA 01/2023
1	OvalbuminIBA 01/2023
1	N- (2- amino- 5- fluorobenzyl)- 4- (N- (pyridine- 3- acrylyl)aminomethyl)benzamideIBA 01/2023
1	CytokinesIBA 01/2023
1	ChemokinesIBA 01/2023
1	Histone Deacetylase InhibitorsIBA 01/2023
1	N-methyladenosineIBA 01/2022
1	Member 2 Group A Nuclear Receptor Subfamily 4IBA 01/2020
1	Twist-Related Protein 1IBA 01/2020
1	18alpha,20beta- hydroxy- 11- oxo- norolean- 12- en- 3beta- yl- 2- O- beta- D- glucopyranurosyl- alpha- D- glucopyranosiduronate magnesium tetrahydrateIBA 01/2020
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2019
1	Antisense RNA (Anti-Sense RNA)IBA 01/2018
1	Cisplatin (Platino)FDA LinkGeneric 10/2017
1	PlatinumIBA 10/2017
1	Competitive Endogenous RNAIBA 02/2017
1	Formaldehyde (Formol)FDA Link 01/2016
1	ParaffinIBA 01/2016
1	Histone Deacetylase 1IBA 01/2016
1	Genetic Markers (Genetic Marker)IBA 10/2014
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 06/2014
1	Indicators and Reagents (Reagents)IBA 06/2014
1	SolutionsIBA 01/2014
1	glutathione S-transferase M1IBA 02/2013
1	Cyclin D1IBA 01/2013
1	chamaejasmineIBA 09/2011
1	Matrix Metalloproteinases (MMPs)IBA 12/2008
1	Small Interfering RNA (siRNA)IBA 12/2008
1	tissue-factor-pathway inhibitor 2 (PP5)IBA 04/2008
1	Thromboplastin (Tissue Factor)IBA 04/2008

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 01/2024 - 10/2017
1	Therapeutics 01/2024
1	Radiotherapy 01/2024
1	Immunotherapy 01/2024
1	Laryngoscopes 01/2022